SCHEMBL3010478

SCHEMBL3010478

C/C=C(/COC(C)=O)OC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.35
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PGR P06401 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
HTR1A P08908 1/20 0.33
CHRNB2 P17787 1/20 0.33
TBXA2R P21731 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
CHRNA10 Q9GZZ6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525172 1.00 ALDH1A1 (0.41) ALDH1A1TSHRHSD17B10LMNATDP1
SCHEMBL7160702 0.81 ALDH1A1 (0.41) ALDH1A1TSHRHSD17B10TDP1
SCHEMBL7160703 0.81 ALDH1A1 (0.41) ALDH1A1TSHRHSD17B10TDP1
SCHEMBL9928633 0.80 ALDH1A1 (0.36) ALDH1A1TSHRHSD17B10LMNATDP1
SCHEMBL9928634 0.80 ALDH1A1 (0.36) ALDH1A1TSHRHSD17B10LMNATDP1
SCHEMBL531366 0.77
SCHEMBL531365 0.77
SCHEMBL10336145 0.75
SCHEMBL6671546 0.72
SCHEMBL2397840 0.72 ALDH1A1 (0.47) ALDH1A1TSHRHSD17B10LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100196287-A1 Compositions Comprising Perhydrolases and Alkylene Glycol Diacetates HENKEL AG & CO. KGAA (DE) 2010-08-05 US disclosed
US-6559347-B2 As dienophiles with dienes such as cyclopentadiene and cyclohexadiene, at an elevated pressure WAKE FOREST UNIVERSITY HEALTH SCIENCES 2003-05-06 US disclosed
US-20020173668-A1 Diels-alder adducts of epoxybutene and epoxybutene derivatives WAKE FOREST UNIVERSITY 2002-11-21 US disclosed
US-6380447-B1 PRESSURIZATION; FORMING BICYCLIC COMPOUNDS WAKE FOREST UNIVERSITY 2002-04-30 US disclosed
US-4661646-A Process for the preparation of 1-butene-3,4-diol BAYER AKTIENGESELLSCHAFT (DE) 1987-04-28 US disclosed
US-4238356-A REACTION PRODUCT OF A CARBOXYLIC ACID, SELENIUM DIOXIDE, A HYDROXIDE OR ACID SALT, AND AN ACID ANHYDRIDE PHILLIPS PETROLEUM COMPANY (US) 1980-12-09 US disclosed
US-4182901-A AND SUITABLE CARBOXYLIC ACID PHILLIPS PETROLEUM COMPANY (US) 1980-01-08 US disclosed
US-4164616-A FROM THE CONJUGATED DIENE PHILLIPS PETROLEUM COMPANY (US) 1979-08-14 US disclosed
US-4121039-A REACTING CONJUGATED DIENE WITH OXYGEN, CATALYST SELECTIVITY GAF CORPORATION (US) 1978-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173668-A1 Diels-alder adducts of epoxybutene and epoxybutene derivatives DERA, CYP11B1, SQLE ALDH1A1 19/4885TSHR 4885/4885HSD17B10 188/4885
US-20100196287-A1 Compositions Comprising Perhydrolases and Alkylene Glycol Diacetates HDHD5, MGLL, DAGLA ALDH1A1 286/4885TSHR 4089/4885HSD17B10 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.